1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Atlantic Healthcare plc

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Essex UK

Primary Industry

Pharmaceuticals

About

Atlantic Healthcare plc is a UK-based company that operates as a developer of pharmaceutical products.
Current Investors
LDC, Envestors, Salix Pharmaceuticals, Ltd.

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.atlantichc.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2010
-
-
(347,746)
-
(346,910)
-
(346,575)
-
31 Dec 2011
-
-
-
-
-
-
-
-
31 Dec 2012
-
-
-
-
-
-
-
-
31 Dec 2013
0
-
(595,641)
-
(587,763)
-
(591,431)
-
31 Dec 2014
0
-
(487,793)
-
(483,207)
-
(486,939)
-
31 Dec 2015
0
-
(661,391)
-
(658,861)
-
(648,045)
-
31 Dec 2016
86,668
-
(5,704,058)
(6581.5%)
(5,674,615)
(6547.5%)
(4,820,004)
(5561.5%)
31 Dec 2017
43,142
(50.2%)
(8,972,215)
(20796.9%)
(8,932,890)
(20705.8%)
(7,206,934)
(16705.1%)
31 Dec 2018
31 Dec 2019
31 Dec 2020

Unlock the recent years of financials and more for Atlantic Healthcare plc.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.